Posterior vitreous detachment (PVD) refers to the separation of the vitreous gel from the retina. It occurs naturally with age as the vitreous liquefies. Symptoms include floaters, flashes of light, and blurred vision. Signs include seeing the detached vitreous gel and hemorrhage in the eye. Ultrasound and OCT can confirm PVD. Patients with risk factors or new concerning symptoms should be examined and followed up, while others may not need follow up unless symptoms return.
Telangiectasic changes in Retina due to telangiectasia.
It can be maily due to systemic causes.
References :- Clinical ophthalmology & comprehensive ophthalmology
Presenting Author: Dr. Saudamini Jadhav, 2nd year resident, MVPS Dr.Vasantrao Pawar Medical College, Nashik. Guide: Dr. Mrunal Patil. Professor & Dean, MVPS Dr.Vasantrao Pawar Medical College, Nashik. Co-Author: Dr. Dhiraj Balwir. Associate Professor, MVPS Dr.Vasantrao Pawar Medical College, Nashik.
Telangiectasic changes in Retina due to telangiectasia.
It can be maily due to systemic causes.
References :- Clinical ophthalmology & comprehensive ophthalmology
Presenting Author: Dr. Saudamini Jadhav, 2nd year resident, MVPS Dr.Vasantrao Pawar Medical College, Nashik. Guide: Dr. Mrunal Patil. Professor & Dean, MVPS Dr.Vasantrao Pawar Medical College, Nashik. Co-Author: Dr. Dhiraj Balwir. Associate Professor, MVPS Dr.Vasantrao Pawar Medical College, Nashik.
This ppt describe about the incidence, diagnosis and management of maculopathy in caaes of pathological myopia.
Data collected and created by Vivek Chaudhary
For queries : vivek977optom@gmail.com
Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated with irregular defects in the juxtapapillary choroid and pigment epithelium. Macular fibers passing through this area often are affected and corresponding changes in the retinal ganglion cell layer and in the visual field occur.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
2. INTRODUCTION
Posterior vitreous detachment (PVD) refers to separation of the cortical vitreous, along with the
delineating posterior hyaloid membrane (PHM), from the neurosensory retina posterior to the vitreous
base.
PVD occurs due to vitreous gel liquefaction with age (synchysis) to form fluid-filled cavities and
subsequently condensation (syneresis), with access to the preretinal space allowed by a dehiscence in
the cortical gel and/or PHM
The prevalence of PVD increases with age, and in individuals in their 80s is likely to be at least 60%.
It is typically spontaneous, but can be induced by events such as cataract surgery, trauma, uveitis and
panretinal photocoagulation.
3. • Perifoveal hyaloid detachment is followed by foveal separation, then detachment from the posterior
retina as far as the equator, attachment initially being retained at the optic disc.
(A) Synchysis and syneresis (B) complete posterior vitreous detachment
4. CLINICAL FEATURES - SYMPTOMS
Flashing lights (photopsia) in PVD is often described as a lightning-like arc induced by eye or head
movement, and is more noticeable in dim illumination.
Floaters (myodesopsia) are mobile vitreous opacities most evident against a bright pale background.
They are often described as spots, cobwebs or flies (muscae volitantes), and are commonly present in
individuals without a PVD, especially myopes.
A Weiss ring is the detached former attachment to the margin of the optic disc, and may be seen by the
patient as a circle or other large solitary lesion; its presence does not necessarily indicate total PVD, nor
does its absence confirm the absence of PVD since it may be destroyed during the process of separation.
5. (C) biomicroscopy showing vitreous
condensation in a pseudophakic eye
(D) vitreous degenerative condensation on wide-
field imaging
(E) Weiss ring on slit lamp biomicroscopy, with
the optic disc in the background
(F) Weiss ring on wide-field imaging
6. Floaters can also be due to vitreous blood.
Blurred vision. A diffuse haze may be due to dispersed haemorrhage within the vitreous gel, with a
variable accompanying reduction in VA
Bleeding can arise from a torn retinal blood vessel or from the site of a retinal break.
Blurring can also be caused by a visually significant PHM or floaters in the visual axis, which may also
cause impairment of acuity.
7. SIGNS
The detached PHM can often be seen clinically on slit lamp examination as a crumpled translucent membrane
in the mid-vitreous cavity behind which the cavity is optically clear.
Haemorrhage may be indicated by the presence of red blood cells in the anterior vitreous or as (usually small)
focal intragel collections, or preretinally, when it sometimes forms a crescent shape bordering the limit of PHM
detachment.
Pigment granules in the anterior vitreous on slit lamp examination (the Shafer sign or ‘tobacco dust’) are
larger, darker and less reflective than red blood cells. Their presence raises the possibility of a retinal break
Vitreous cells, if numerous, may signify the presence of a break.
Retinal breaks.
12. MANAGEMENT
Patients should be examined with acute symptoms of PVD, usually in the presence of risk factors such as,
Myopia, RD, high risk syndromes like, stickler’s syndrome and symptoms like visual field defects, reduced
vision or prominent floaters.
If there is only a single small floater and no photopsia, evidence suggests the risk of retinal break in the
symptomatic eye.
13. EXAMINATION
The anterior vitreous should be assessed for the presence of blood and pigment.
Examination of the ors seratta and 360° should be performed
Binocular indirect ophthalmoscopy or contact lens scleral indentation.
An asymptomatic fellow eye should always be examined.
14. SUBSEQUENT MANAGEMENT
If there are no suspicious findings (e.g. vitreous blood) on examination and no pre-existing risk factors as
discussed above then routine review may not be necessary.
The presence of features associated with higher risk should lead to review after an interval of 1–6 weeks
depending on individual characteristics.
Some authorities recommend further review in 6–12 months.
Patients who present with multiple prominent floaters or hazy vision should be reviewed carefully as this
has been found to be associated with a higher risk of retinal break.
15. Discharged patients should be given clear instructions emphasizing the need to re-attend urgently in the
event of significant new symptoms.
Optimally, written information about the advice should be provided.
If an area of the fundus cannot be viewed clearly due to obscuration by blood then weekly review is
prudent.
Presentation with diffuse fundus-obscuring vitreous haemorrhage (in the absence of a condition
predisposing to non-PVD vitreous haemorrhage) is associated with a very high risk of retinal break (90%)
and retinal detachment (40%).
16. B-scan ultrasonography performed regularly until resolution in order to exclude an underlying
detachment or identifiable break.
A very low threshold for vitrectomy should be adopted, particularly in the presence of other risk factors,
notably prior RD in the fellow eye.
The management of retinal breaks should be carried out in the case of Retinal
breaks